The Enterprise Value as of December 2024 (TTM) for Revelation Biosciences, Inc. (REVB) is -4075884.00

According to Revelation Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -4075884.00. This represents a change of -50.51% compared to the average of -8236139.53 of the last 4 quarters.

Revelation Biosciences, Inc. (REVB) Historical Enterprise Value (quarterly & annually)

How has REVB Enterprise Value performed in the past?

The mean historical Enterprise Value of Revelation Biosciences, Inc. over the last ten years is 52.99M. The current -4075884.00 Enterprise Value has changed -869.24% with respect to the historical average. Over the past ten years (40 quarters), REVB's Enterprise Value was at its highest in in the September 2021 quarter at 87.60M. The Enterprise Value was at its lowest in in the March 2023 quarter at -14828908.00.

Revelation Biosciences, Inc. (REVB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Revelation Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Revelation Biosciences, Inc. (REVB) Average Enterprise Value

How has REVB Enterprise Value performed in the past?

The current Enterprise Value of Revelation Biosciences, Inc. (REVB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Revelation Biosciences, Inc. (REVB) Enterprise Value vs. Peers

How is REVB’s Enterprise Value compared to its peers?

Revelation Biosciences, Inc.’s Enterprise Value is less than Virax Biolabs Group Limited (4.23M), less than Blue Water Vaccines, Inc. (12.54M), less than Hillstream BioPharma, Inc. (1.48M), less than Kiora Pharmaceuticals, Inc. (4.25M), less than ZyVersa Therapeutics, Inc. (2.55M), less than Sonnet BioTherapeutics Holdings, Inc. (4.67M), less than Navidea Biopharmaceuticals, Inc. (-2595051.00), less than Altamira Therapeutics Ltd. (497.26K), greater than Zura Bio Limited (-39351752.00), less than Phio Pharmaceuticals Corp. (-3532813.00), less than TransCode Therapeutics, Inc. (894.46K), less than Quoin Pharmaceuticals, Ltd. (-243459.00), less than PaxMedica, Inc. Common Stock (524.09K),

Build a custom stock screener for Revelation Biosciences, Inc. (REVB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revelation Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Revelation Biosciences, Inc. (REVB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Revelation Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.